Table 2 The surgical methods and intraoperative and postoperative conditions
From: A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal
No | Etiology | BCVA pre-op | BCVA post-op | Treatment | Surgical | Surgery duration | BP enter | BPmax During | BP back to |
|---|---|---|---|---|---|---|---|---|---|
(Snellen) | (Snellen) | pre-OP | procedure | (minutes) | OR(mmHg) | OP(mmHg) | ward(mmHg) | ||
1 | PDR,TRD | HM | LP | / | PPV + P + I + PRP + SO | 72 | 165/100 | 160/100 | 150/80 |
2 | PDR,VH | FC | 20/100 | PRP | PPV + PRP | 28 | 160/95 | 160/90 | 130/80 |
3 | PDR,VH | FC | 20/30 | / | PPV + P + I + PRP | 55 | 142/85 | 165/95 | 130/80 |
4 | PDR,VH,ERM | 20/200 | 20/40 | PRP,IV Cbcp | PPV + P + I + PRP + IVTA | 45 | 165/88 | 175/100 | 120/70 |
5 | PDR,VH | 20/100 | 20/50 | PRP | PPV + P + I + PRP | 52 | 150/90 | 160/100 | 150/80 |
6 | PDR,VH | HM | 20/500 | IV Cbcp | PPV + P + I + PRP + IVTA | 53 | 162/92 | 160/90 | 150/90 |
7 | PDR,TRD | HM | 20/200 | IV Cbcp | PPV + P + I + PRP + SO | 62 | 185/102 | 190/100 | 160/90 |
8 | PDR,BRVO | HM | 20/150 | PRP,IV Cbcp | PPV + P + I + PRP + IVTA | 45 | 180/100 | 180/90 | 130/80 |
9 | PDR.VH | FC | 20/100 | PRP | PPV + P + I + PRP + IVTA | 50 | 162/95 | 180/80 | 140/80 |
10 | PDR,VH | FC | 20/20 | IV Cbcp | PPV + P + I + PRP + IVTA | 48 | 150/92 | 160/90 | 150/90 |
11 | PDR,VH | FC | 20/25 | / | PPV + P + I + PRP + IVTA | 52 | 158/89 | 160/90 | 150/90 |
12 | VH,BRVO | HM | 20/60 | / | PPV + P + I + LRP + IVTA | 62 | 220/105 | 175/95 | 140/80 |
13 | VH,BRVO | 20/400 | 20/30 | / | PPV + LRP + SO | 62 | 138/85 | 160/80 | 160/75 |
14 | PDR,VH,BRVO | 20/500 | 20/40 | IV Cbcp | PPV + P + I + PRP + IVTA | 32 | 145/92 | 200/100 | 130/80 |
15 | HR | 20/400 | 20/100 | / | PPV + PRP + IVTA | 28 | 230/110 | 200/110 | 170/110 |
16 | PDR,VH | 20/500 | 20/300 | IV Cbcp | PPV + PRP + IVTA | 28 | 200/100 | 150/90 | 130/80 |